Market Value5,935,681,007
Total Holdings63
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VOR / Vor Biopharma Inc.
CDTX / Cidara Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
SEPN / Septerna, Inc.
SION / Sionna Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
XNCR / Xencor, Inc.
ITOS / iTeos Therapeutics, Inc.
BOLD / Boundless Bio, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
CBLL / CeriBell, Inc.
APGE / Apogee Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
GKOS / Glaukos Corporation
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
BIOA / BioAge Labs, Inc.
ARTV / Artiva Biotherapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
SCILEX HOLDING CO / SH (80880W106)
INSM / Insmed Incorporated
NRIX / Nurix Therapeutics, Inc.
LXEO / Lexeo Therapeutics, Inc.
KURA / Kura Oncology, Inc.
IMTX / Immatics N.V.
ABOS / Acumen Pharmaceuticals, Inc.
GERN / Geron Corporation
SRRK / Scholar Rock Holding Corporation
SERA / Sera Prognostics, Inc.
ATXS / Astria Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
GHRS / GH Research PLC
STRO / Sutro Biopharma, Inc.
ETNB / 89bio, Inc.
TNGX / Tango Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
ZURA / Zura Bio Limited
LRMR / Larimar Therapeutics, Inc.
MTSR / Metsera, Inc.
JANX / Janux Therapeutics, Inc.
JBIO / Jade Biosciences, Inc.
NKTX / Nkarta, Inc.
IFRX / InflaRx N.V.
DRUG / Bright Minds Biosciences Inc.
ELDN / Eledon Pharmaceuticals, Inc.
ACRV / Acrivon Therapeutics, Inc.
URGN / UroGen Pharma Ltd.
MNPR / Monopar Therapeutics Inc.
HUMA / Humacyte, Inc.
BCAX / Bicara Therapeutics Inc.
NAMS / NewAmsterdam Pharma Company N.V.
LENZ / LENZ Therapeutics, Inc.
BBNX / Beta Bionics, Inc.
TVTX / Travere Therapeutics, Inc.
ELVN / Enliven Therapeutics, Inc.
MBX / MBX Biosciences, Inc.
CTMX / CytomX Therapeutics, Inc.
PCSC / Perceptive Capital Solutions Corp
TARA / Protara Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
SRZN / Surrozen, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SPRY / ARS Pharmaceuticals, Inc.
ACHC / Acadia Healthcare Company, Inc.
WGS / GeneDx Holdings Corp.
CLYM / Climb Bio, Inc.
ACLX / Arcellx, Inc.
DYN / Dyne Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
RXST / RxSight, Inc.
DNTH / Dianthus Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ACET / Adicet Bio, Inc.
IRON / Disc Medicine, Inc.
PEPG / PepGen Inc.
HOWL / Werewolf Therapeutics, Inc.
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
TXG / 10x Genomics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
TYRA / Tyra Biosciences, Inc.
MLYS / Mineralys Therapeutics, Inc.
HNGE / Hinge Health, Inc.
ALEC / Alector, Inc.
WVE / Wave Life Sciences Ltd.
OMDA / Omada Health, Inc.